Biopharmaceuticals and Government - Partnership Management Hub

Top 14 BioPharmaceutical Consultants & Consulting Firms

Jake Jorgovan

NOVEMBER 29, 2023

Biopharmaceutical consultants and consulting firms play a pivotal role in guiding companies through the intricate landscape of drug development, regulatory compliance, and market strategies. This foresight is particularly crucial in an industry where innovation is the key to success and survival.

Biopharmaceuticals

Biopharmaceuticals Biopharma Biotech Life science

Top 18 Medical Device Consultants & Consulting Firms

Jake Jorgovan

NOVEMBER 28, 2023

The Windshire Group: Is a comprehensive life science and management consulting firm founded in 2011 focusing on the pharmaceutical and biopharmaceutical industries. Their global presence and diverse range of services ensure a holistic and effective strategy for any project in the pharmaceutical and biopharmaceutical sectors.

Life science

Life science Biopharmaceuticals Biotech Partnering capability and readiness

Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for Its Competitive Strategies

Frost & Sullivan

APRIL 25, 2023

Emmes is a full-service, global Clinical Research Organization (CRO) committed to promoting public health and biopharmaceutical innovation. The company collaborates with biopharmaceutical, governmental, non-profit, and academic organizations to enhance its value proposition and meet client demands.

Biopharmaceuticals

Biopharmaceuticals Biopharma Biotechnology Contract research organization

Delivering responsible AI in the healthcare and life sciences industry

IBM Business Partners

JANUARY 3, 2024

With today’s new generative AI products, trust, security and regulatory issues remain top concerns for government healthcare officials and C-suite leaders representing biopharmaceutical companies, health systems, medical device manufacturers and other organizations.

Life science

Life science Biopharmaceuticals Government Engineering

Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe

Frost & Sullivan

JULY 22, 2021

As a result, academic labs and small biotech companies are accelerating RNA therapeutics research, alongside Tier 1 biopharmaceutical companies.” . “RNAs are relatively easy to manufacture, cost-effective, and can act on undruggable targets. About Frost & Sullivan.

Biotech

Biotech Biopharmaceuticals Biotechnology Government

Digital Technologies Drive Growth Across the Biomanufacturing Value Chain

Frost & Sullivan

NOVEMBER 29, 2022

Automated processes, remote monitoring, and digital supply chains accelerate biomanufacturing rates of biopharmaceuticals.”. For over six decades, Frost & Sullivan has helped build sustainable growth strategies for Fortune 1000 companies, governments, and investors. About Frost & Sullivan.

Biopharmaceuticals

Biopharmaceuticals Government

Avance Clinical Earns Frost & Sullivan’s 2023 Best Practices Customer Value Leadership Award for Delivering High-quality Clinical Trials Based on Globally Accepted Data

Frost & Sullivan

AUGUST 6, 2023

“The company understands the intricacies of conducting clinical trials for innovative biopharmaceutical products, gene and cell therapies, and other advanced therapies. and rapid start-up regulatory processes that are available in Australia.

Biotechnology

Biotechnology Biotech Contract research organization Biopharmaceuticals

Covance, LabCorp’s Drug Development Business, Acclaimed by Frost & Sullivan for Its Unmatched Breadth of Services to Support Clinical Trials

Frost & Sullivan

DECEMBER 16, 2020

Furthermore, LabCorp Drug Development draws on its deep expertise in antiviral drugs and vaccines, as well as partners with biopharmaceutical companies to develop treatment and vaccines for COVID-19 through improved detection methods.” About Frost & Sullivan.

Biopharmaceuticals

Biopharmaceuticals Life science Contract research organization Government

LifeOmic Applauded by Frost & Sullivan for Enabling More Cost-efficient, Targeted Holistic Precision Health with Its Interoperable Precision Health Solutions

Frost & Sullivan

MAY 16, 2022

The company provides a precision health-specific healthcare system and governance to improve access and awareness, thus driving adoption. It offers novel precision health and wellness software-as-a-service (SaaS) solutions to patients, healthcare providers (HCPs), employers, health plans, and biopharmaceuticals.

Biopharmaceuticals

Biopharmaceuticals Insurance Ecosystems Government

Global Water Scarcity and Hospitalization Rates Stimulate the Polymeric Membranes Market

Frost & Sullivan

JUNE 22, 2021

Invest in Blood Transfusion and Apheresis Membranes to Accelerate Revenue Growth : The increasing demand for blood plasma to create plasma-derived biopharmaceutical products will drive the demand for apheresis and transfusion membranes. About Frost & Sullivan.

Biopharmaceuticals

Biopharmaceuticals Government

Ecosystem Partnerships Extend and Evolve Alliances

Phoenix Consulting Group

JUNE 9, 2020

In a traditional alliance, you can rely on robust governance process to compensate for low trust environments. Instead of steady, linear processes, you have to build in the ability to change and adapt, breaking up the interactions into smaller, timebound sprints, as Agilists would say. Q: What about the supply side versus the demand side?

Ecosystems

Ecosystems Channels and alliances Biopharmaceuticals Insurance

Discover Six Dynamic Trends to Disrupt the Next Generation of Biopharmaceutical Manufacturing

Frost & Sullivan

MAY 12, 2021

May 12, 2021 – The biopharmaceutical industry is facing its biggest test in recent times. A rise in new disease outbreaks, the urgency to launch innovative therapies, and new constructs such as multi-valent antibodies are compelling biopharmaceutical companies to adopt new manufacturing approaches. SANTA CLARA, Calif. –

Biopharmaceuticals

Biopharmaceuticals Life science Construction Government

Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

Frost & Sullivan

AUGUST 9, 2021

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success.

Life science

Life science Biopharma Government Biopharmaceuticals

Frost & Sullivan Reveals How Virtual Care will Impact the Trillion-dollar Global Healthcare Market

Frost & Sullivan

MARCH 30, 2021

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success.

Biotechnology

Biotechnology Life science Government Biopharmaceuticals

Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

Frost & Sullivan

AUGUST 9, 2021

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success.

Life science

Life science Biopharma Government Biopharmaceuticals

Growth Perspectives: Key Highlights from DCAT 2024

Frost & Sullivan

APRIL 3, 2024

AbbVie introduced a customized risk-based governance model for agile and compliant operations in a highly regulated and risk-sensitive environment. A vital requirement is to successfully scale the formulation from clinical to commercial manufacturing quickly.

Biopharmaceuticals

Biopharmaceuticals Biopharma Biotechnology Life science

Frost & Sullivan Reveals How Virtual Care will Impact the Trillion-dollar Global Healthcare Market

Frost & Sullivan

MARCH 30, 2021

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success.

Biotechnology

Biotechnology Life science Government Biopharmaceuticals

Partnership Management Hub

Top 14 BioPharmaceutical Consultants & Consulting Firms

Top 18 Medical Device Consultants & Consulting Firms

Trending Sources

Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for Its Competitive Strategies

Delivering responsible AI in the healthcare and life sciences industry

Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe

Digital Technologies Drive Growth Across the Biomanufacturing Value Chain

Avance Clinical Earns Frost & Sullivan’s 2023 Best Practices Customer Value Leadership Award for Delivering High-quality Clinical Trials Based on Globally Accepted Data

Covance, LabCorp’s Drug Development Business, Acclaimed by Frost & Sullivan for Its Unmatched Breadth of Services to Support Clinical Trials

LifeOmic Applauded by Frost & Sullivan for Enabling More Cost-efficient, Targeted Holistic Precision Health with Its Interoperable Precision Health Solutions

Global Water Scarcity and Hospitalization Rates Stimulate the Polymeric Membranes Market

Ecosystem Partnerships Extend and Evolve Alliances

Discover Six Dynamic Trends to Disrupt the Next Generation of Biopharmaceutical Manufacturing

Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

Frost & Sullivan Reveals How Virtual Care will Impact the Trillion-dollar Global Healthcare Market

Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

Growth Perspectives: Key Highlights from DCAT 2024

Frost & Sullivan Reveals How Virtual Care will Impact the Trillion-dollar Global Healthcare Market

Stay Connected